5
The Platinum Hall of Fame European Urology would like to recognize the award-winning authors and exceptional reviewers who ensure that ‘your’ platinum journal remains a cut above the rest. Best Scientific Paper Prizes 2000 to the Present 2000 Laparoscopic Radical Prostatectomy: Technical and Early Oncological Assessment of 40 Operations B. Guillonneau, X. Cathelineau, E. Barret, F. Rozet, G. Vallancien European Urology 1999;36:14–20 2001 RPLND or Primary Chemotherapy in Clinical Stage IIA/B Nonseminomatous Germ Cell Tumors? Results of a Prospective Multicenter Trial Including Quality of Life Assessment L. Weissbach, R. Bussar-Maatz, H. Flechtner, U. Pichlmeier, M. Hartmann, L. Keller European Urology 2000;37:582–594 2002 Nonrandomized Comparison of Open Flank versus Laparoscopic Nephrectomy in 249 Patients with Benign Renal Disease P. Fornara, C. Doehn, H.-J. Friedrich, D. Jocham European Urology 2001;40:24–31 2003 Laparoscopic Dismembered Pyeloplasty – The Method of Choice in the Presence of an Enlarged Renal Pelvis and Crossing Vessels I.A. Türk, J.W. Davis, B. Winkelmann, S. Deger, F. Richter, M.D. Fabrizio, B. Schönberger, G.H. Jordan, S.A. Loening European Urology 2002;42:268–275 2004 The Side Effects of Bacillus Calmette-Guérin in the Treatment of Ta T1 Bladder Cancer do not Predict its Efficacy: Results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial R.J. Sylvester, A.P.M. Van Der Meijden, W. Oosterlinck, W. Hoeltl, A.V. Bono European Urology 2003;44:423–428 & Maintenance Bacillus Calmette-Guérin for Ta T1 Bladder Tumors is not Associated with Increased Toxicity: Results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial A.P.M. Van Der Meijden, R.J. Sylvester, W. Oosterlinck, W. Hoeltl, A.V. Bono European Urology 2003;44:429–434 2005 DD3 PCA3 RNA Analysis in Urine – A New Perspective for Detecting Prostate Cancer M. Tinzl, M. Marberger, S. Horvath, C. Chypre European Urology 2004;46:182–186 2006 Prevalence of Asymptomatic Coronary Artery Disease in Men with Vasculogenic Erectile Dysfunction: A Prospective Angiographic Study C. Vlachopoulos, K. Rokkas, N. Ioakeimidis, C. Aggeli, A. Michaelides, G. Roussakis, C. Fassoulakis, A. Askitis, C. Stefanadis European Urology 2005;48:996–1002 2007 Excellent Long-Term Cancer Control with Elective Nephron-Sparing Surgery for Selected Renal Cell Carcinomas Measuring More Than 4 cm F. Becker, S. Siemer, M. Hack, U. Humke, M. Ziegler, M. Stöckle European Urology 2006;49:1058–1064 & Elective Nephron-Sparing Surgery Should Become Standard Treatment for Small Unilateral Renal Cell Carcinoma: Long-term Survival Data of 216 Patients F. Becker, S. Siemer, U. Humke, M. Hack, M. Ziegler, M. Stöckle European Urology 2006;49:308–313 2008 Morbidity and Clinical Outcome of Nephron- Sparing Surgery in Relation to Tumour Size and Indication J.-J. Patard, A.J. Pantuck, M. Crepel, J.S. Lam, L. Bellec, B. Albouy, D. Lopes, J.-C. Bernhard, F. Guillé, B. Lacroix, A. De La Taille, L. Salomon, C. Pfister, M. Soulié, J. Tostain, J.-M. Ferriere, C.C. Abbou, M. Colombel, A.S. Belldegrun European Urology 2007;52:148–154 2009 The Template of the Primary Lymphatic Landing Sites of the Prostate Should Be Revisited: Results of a Multimodality Mapping Study A. Mattei , F.G. Fuechsel, N. Bhatta Dhar, S.H. Warncke, G.N. Thalmann, T. Krause, U.E. Studer European Urology 2008;53:118–125 2010 Preoperative Aspects and Dimensions Used for an Anatomical (PADUA) Classification of Renal Tumours in Patients who are Candidates for Nephron-Sparing Surgery V. Ficarra, G. Novara, S. Secco, V. Macchi, A. Porzionato, R. De Caro, W. Artibani European Urology 2009;56:786–793 Sponsored By Elsevier 2011 Positive Surgical Margin Appears to Have Negligible Impact on Survival of Renal Cell Carcinomas Treated by Nephron-Sparing Surgery K. Bensalah, A.J. Pantuck, N. Rioux-Leclercq, R. Thuret, F. Montorsi, P. Karakiewicz, N. Mottet, L. Zini, R. Bertini, L. Salomon, A. Villers, M. Soulie, L. Bellec, P. Rischmann, A. De La Taille, R. Avakian, M. Crepel, J. Ferriere, J. Bernhard, T. Dujardin, et al. European Urology 2010;57:466–473 Sponsored By Elsevier http://dx.doi.org/10.1016/S0302-2838(13)00517-4

Award pages

  • Upload
    lamkiet

  • View
    217

  • Download
    1

Embed Size (px)

Citation preview

Page 1: Award pages

The PlatinumHall of Fame

European Urology would like to recognize the award-winning authors and exceptional reviewers who ensure that ‘your’ platinum journal remains a cut above the rest.

Best Scientifi c Paper Prizes 2000 to the Present

2000Laparoscopic Radical Prostatectomy: Technical and Early Oncological Assessment of 40 Operations B. Guillonneau, X. Cathelineau, E. Barret, F. Rozet, G. VallancienEuropean Urology 1999;36:14–20

2001RPLND or Primary Chemotherapy in Clinical Stage IIA/B Nonseminomatous Germ Cell Tumors? Results of a Prospective Multicenter Trial Including Quality of Life AssessmentL. Weissbach, R. Bussar-Maatz, H. Flechtner, U. Pichlmeier, M. Hartmann, L. KellerEuropean Urology 2000;37:582–594

2002Nonrandomized Comparison of Open Flank versus Laparoscopic Nephrectomy in 249 Patients with Benign Renal DiseaseP. Fornara, C. Doehn, H.-J. Friedrich, D. JochamEuropean Urology 2001;40:24–31

2003Laparoscopic Dismembered Pyeloplasty – The Method of Choice in the Presence of an Enlarged Renal Pelvis and Crossing VesselsI.A. Türk, J.W. Davis, B. Winkelmann, S. Deger, F. Richter, M.D. Fabrizio, B. Schönberger, G.H. Jordan, S.A. Loening European Urology 2002;42:268–275

2004The Side Effects of Bacillus Calmette-Guérin in the Treatment of Ta T1 Bladder Cancer do not Predict its Effi cacy: Results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III TrialR.J. Sylvester, A.P.M. Van Der Meijden, W. Oosterlinck, W. Hoeltl, A.V. BonoEuropean Urology 2003;44:423–428&Maintenance Bacillus Calmette-Guérin for Ta T1 Bladder Tumors is not Associated with Increased Toxicity: Results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III TrialA.P.M. Van Der Meijden, R.J. Sylvester, W. Oosterlinck, W. Hoeltl, A.V. BonoEuropean Urology 2003;44:429–434

2005DD3PCA3 RNA Analysis in Urine – A New Perspective for Detecting Prostate CancerM. Tinzl, M. Marberger, S. Horvath, C. ChypreEuropean Urology 2004;46:182–186

2006Prevalence of Asymptomatic Coronary Artery Disease in Men with Vasculogenic Erectile Dysfunction: A Prospective Angiographic StudyC. Vlachopoulos, K. Rokkas, N. Ioakeimidis, C. Aggeli, A. Michaelides, G. Roussakis, C. Fassoulakis, A. Askitis, C. StefanadisEuropean Urology 2005;48:996–1002

2007Excellent Long-Term Cancer Control with Elective Nephron-Sparing Surgery for Selected Renal Cell Carcinomas Measuring More Than 4 cmF. Becker, S. Siemer, M. Hack, U. Humke, M. Ziegler, M. StöckleEuropean Urology 2006;49:1058–1064&Elective Nephron-Sparing Surgery Should Become Standard Treatment for Small Unilateral Renal Cell Carcinoma: Long-term Survival Data of 216 PatientsF. Becker, S. Siemer, U. Humke, M. Hack, M. Ziegler, M. StöckleEuropean Urology 2006;49:308–313

2008Morbidity and Clinical Outcome of Nephron-Sparing Surgery in Relation to Tumour Size and IndicationJ.-J. Patard, A.J. Pantuck, M. Crepel, J.S. Lam, L. Bellec, B. Albouy, D. Lopes, J.-C. Bernhard, F. Guillé, B. Lacroix, A. De La Taille, L. Salomon, C. Pfi ster, M. Soulié, J. Tostain, J.-M. Ferriere, C.C. Abbou, M. Colombel, A.S. BelldegrunEuropean Urology 2007;52:148–154

2009The Template of the Primary Lymphatic Landing Sites of the Prostate Should Be Revisited: Results of a Multimodality Mapping Study A. Mattei , F.G. Fuechsel, N. Bhatta Dhar, S.H. Warncke, G.N. Thalmann, T. Krause, U.E. StuderEuropean Urology 2008;53:118–125

2010Preoperative Aspects and Dimensions Used for an Anatomical (PADUA) Classifi cation of Renal Tumours in Patients who are Candidates for Nephron-Sparing SurgeryV. Ficarra, G. Novara, S. Secco, V. Macchi, A. Porzionato, R. De Caro, W. ArtibaniEuropean Urology 2009;56:786–793Sponsored By Elsevier

2011Positive Surgical Margin Appears to Have Negligible Impact on Survival of Renal Cell Carcinomas Treated by Nephron-Sparing Surgery K. Bensalah, A.J. Pantuck, N. Rioux-Leclercq, R. Thuret, F. Montorsi, P. Karakiewicz, N. Mottet, L. Zini, R. Bertini, L. Salomon, A. Villers, M. Soulie, L. Bellec, P. Rischmann, A. De La Taille, R. Avakian, M. Crepel, J. Ferriere, J. Bernhard, T. Dujardin, et al.European Urology 2010;57:466–473Sponsored By Elsevier

http://dx.doi.org/10.1016/S0302-2838(13)00517-4

Page 2: Award pages

The PlatinumHall of Fame

2012Pentafecta: A New Concept for Reporting Outcomes of Robot-Assisted Laparoscopic Radical ProstatectomyV. Patel, A. Sivaraman, R. Coelho, S. Chauhan, K. Palmer, M. Orvieto, I. Camacho, G. Coughlin, B. RoccoEuropean Urology 2011;59:702–707

2013Pathologic Downstaging Is a Surrogate Marker for Effi cacy and Increased Survival Following Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Urothelial Bladder CancerR. Rosenblatt, A. Sherif, E. Rintala, R. Wahlqvist, A. Ullén, S. Nilsson, P.-U. Malmström, the Nordic Urothelial Cancer GroupEuropean Urology 2012;61:1229–1238

Best Clinical Research Paper published from an author under 35

2007Frozen Section for the Management of Intraoperatively Detected Palpable Tumor Lesions During Nerve-Sparing Scheduled Radical ProstatectomyC. Eichelberg, A. Erbersdobler, A. Haese, T. Schlomm, F.K.H. Chun, E. Currlin, J. Walz, T. Steuber, M. Graefen, H. HulandEuropean Urology 2006;49:1011–1018

2008Use of Haemostatic Agents and Glues during Laparoscopic Partial Nephrectomy: A Multi-Institutional Survey from the United States and Europe of 1347 CasesA. Breda, S.V. Stepanian, J.S. Lam, J.C. Liao, I.S. Gill, J.R. Colombo, G. Guazzoni, M.D. Stifelman, K.T. Perry, A. Celia, G. Breda, P. Fornara, S.V. Jackman, A. Rosales, J. Palou, M. Grasso, V. Pansadoro, V. Disanto, F. Porpiglia, C. Milani, C.C. Abbou, R. Gaston, G. Janetschek, N.A. Soomro, J.J. De la Rosette, P.M. Laguna, P.G. SchulamEuropean Urology 2007;52:798–803

2009Predictive Factors for Progression in Patients with Clinical Stage T1a Prostate Cancer in the PSA EraA. Descazeaud, M. Peyromaure, A. Salin, D. Amsellem-Ouazana, T. Flam, A. Viellefond, B. Debré, M. ZerbibEuropean Urology 2008;53:355–362

2010Should All Patients with Non–Muscle-Invasive Bladder Cancer Receive Early Intravesical Chemotherapy after Transurethral Resection? The Results of a Prospective Randomised Multicentre StudyS. Gudjónsson, L. Adell, F. Merdasa, R. Olsson, B. Larsson, T. Davidsson, J. Richthoff, G. Hagberg, M. Grabe, P.O. Bendahl, W. Månsson, F. LiedbergEuropean Urology 2009;55:773–780Sponsored By Eli Lilly

2011Complications in 2200 Consecutive Laparoscopic Radical Prostatectomies: Standardized Evaluation and Analysis of Learning CurvesM. Hruza, H. Weiß, G. Pini, A. Goezen, M. Schulze, D. Teber, J. RassweilerEuropean Urology 2010;58:733–741Sponsored by Elsevier

2012Salvage Radical Prostatectomy for Radiation-recurrent Prostate Cancer: A Multi-institutional CollaborationD. Chade, S. Shariat, A. Cronin, C. Savage, J. Karnes, M. Blute, A. Briganti, F. Montorsi, H. van der Poel, H. Van Poppel, S. Joniau, G. Godoy, A. Hurtado-Coll, M. Gleave, M. Dall’Oglio, M. Srougi, P. Scardino, J. EasthamEuropean Urology 2011;60:205–210

2013Stage-Specifi c Impact of Tumor Location on Oncologic Outcomes in Patients With Upper and Lower Tract Urothelial Carcinoma Following Radical SurgeryM. Rink, B. Ehdaie, E.K. Cha, D.A. Green, P.I. Karakiewicz, M. Babjuk, V. Margulis, J.D. Raman, R.S. Svatek, H. Fajkovic, R.K. Lee, G. Novara, J. Hansen, S. Daneshmand, Y. Lotan, W. Kassouf, H.-M. Fritsche, A. Pycham, M. Fisch, D.S. Scherr, S.F. Shariat, for the Bladder Cancer Research Consortium (BCRC) and for the Upper Tract Urothelial Carcinoma Collaboration (UTUCC)European Urology 2012;62:677–684

Best Fundamental Research Paper published from an author under 35

2007Depressed Contractile Responses to Neurokinin A in Idiopathic but not Neurogenic Overactive Human Detrusor MuscleD.J. Sellers, C.R. Chapple, D.P.W. Hay, R. Chess-WilliamsEuropean Urology 2006;49:510–518

2008Effects of the M3 Receptor Selective Muscarinic Antagonist Darifenacin on Bladder Afferent Activity of the Rat Pelvic NerveK. Iijima, S. De Wachter, J.-J. WyndaeleEuropean Urology 2007;52:842–849

2009Marked Gene Transcript Level Alterations Occur Early During Radical ProstatectomyT. Schlomm, E. Näkel, A. Lübke, A. Buness, F.K.-H. Chun, T. Steuber, M. Graefen, R. Simon, G. Sauter, A. Poustka, H. Huland, A. Erbersdobler, H. Sültmann, O.J.C. HellwinkelEuropean Urology 2008;53:333–346

2010Characteristics of Spontaneous Activity in the Bladder TrigoneA. Roosen, C. Wu, G. Sui, R.A. Chowdhury, P.M. Patel, C.H. FryEuropean Urology 2009;56:346–354Sponsored By Elsevier

2011Stem Cell Characteristics in Prostate Cancer Cell Lines M.J. Pfeiffer, J.A. Schalken European Urology 2010;57:246–255Sponsored By Elsevier

Page 3: Award pages

The PlatinumHall of Fame

2012Transplantation of Autologous Differentiated Urothelium in an Experimental Model of Composite CystoplastyA. Turner, R. Subramanian, D. Thomas, J. Hinley, S. Abbas, J. Stahlschmidt, J. SouthgateEuropean Urology 2011;59:447–454

2013Genome-wide Analysis of CpG Island Methylation in Bladder Cancer Identifi ed TBX2, TBX3, GATA2, and ZIC4 as pTa-Specifi c Prognostic MarkersR. Kandimalla, A.A.G. van Tilborg, L.C. Kompier, D.J.P.M. Stumpel, R.W. Stam, C.H. Bangma, E.C. ZwarthoffEuropean Urology 2012;61:1245–1256

Residents’ Corner

2008Initial Biopsy Outcome Prediction—Head-to-Head Comparison of a Logistic Regression-Based Nomogram versus Artifi cial Neural NetworkF.K.-H. Chun, M. Graefen, A. Briganti, A. Gallina, J. Hopp, M.W. Kattan, H. Huland, P.I. KarakiewiczEuropean Urology 2007;51:1236–1243&hK2 and Free PSA, a Prognostic Combination in Predicting Minimal Prostate Cancer in Screen-Detected Men within the PSA Range 4–10 ng/mlR. Raaijmakers, S.H. de Vries, B.G. Blijenberg, M.F. Wildhagen, R. Postma, C.H. Bangma, C. Darte, F.H. SchröderEuropean Urology 2007;52:1358–1364

2009Evaluation of Prostate Cancer Detection with Ultrasound Real-Time Elastography: A Comparison with Step Section Pathological Analysis after Radical ProstatectomyG. Salomon, J. Köllerman, I. Thederan, F.K.H. Chun, L. Budäus, T. Schlomm, H. Isbarn, H. Heinzer, H. Huland, M. GraefenEuropean Urology 2008;54:1354–1362

&Radical Prostatectomy for Incidental (Stage T1a–T1b) Prostate Cancer: Analysis of Predictors for Residual Disease and Biochemical RecurrenceU. Capitanio, V. Scattoni, M. Freschi, A. Briganti, A. Salonia, A. Gallina, R. Colombo, P.I. Karakiewicz, P. Rigatti, F. MontorsiEuropean Urology 2008;54:118–125

2010Infl uence of Nerve Transsections and Combined Bladder Filling on Intravesical Electrostimulation-Induced Bladder Contraction in the RatF. De Bock, S. De Wachter, J.J. WyndaeleEuropean Urology 2009;56:527–533Sponsored By Eli Lilly

&The Role of Biopsy Core Number in Selecting Prostate Cancer Patients for Active SurveillanceG. Ploussard, E. Xylinas, L. Salomon, Y. Allory, D. Vordos, A. Hoznek, C.-C. Abbou, A. de la TailleEuropean Urology 2009;56:891–898Sponsored By Eli Lilly

2011Midterm Prospective Evaluation of TVT-Secur Reveals High Failure Rate J.N. Cornu, P. Sèbe, L. Peyrat, C. Ciofu, O. Cussenot, F. HaabEuropean Urology 2010;58:157–161&HYAL-1 Hyaluronidase: A Potential Prognostic Indicator for Progression to Muscle Invasion and Recurrence in Bladder Cancer M.W. Kramer, R. Golshani, A.S. Merseburger, J. Knapp, A. Garcia, J. Hennenlotter, R.C. Duncan, M.S. Soloway, M. Jorda, M.A. Kuczyk, A. Stenzl, V.B. Lokeshwar European Urology 2010;57:86–94

2012Exosomes as Biomarker Treasure Chests for Prostate CancerD. Duijvesz, T. Luider, C. Bangma, G. JensterEuropean Urology 2011;59:823–831&Cancer-Specifi c and Other-Cause Mortality After Radical Prostatectomy Versus Observation in Patients with Prostate Cancer: Competing-Risks Analysis of a Large North American Population-Based CohortF. Abdollah, M. Sun, J. Schmitges, Z. Tian, C. Jeldres, A. Briganti, S. Shariat, P. Perrotte, F. Montorsi, P. KarakiewiczEuropean Urology 2011;60:920–930

2013Prospective Assessment of Prostate Cancer Aggres-siveness Using 3-T Diffusion-Weighted Magnetic Resonance Imaging–Guided Biopsies Versus a Systematic 10-Core Transrectal Ultrasound Prostate Biopsy CohortT. Hambrock, C. Hoeks, C. Hulsbergen-van de Kaa, T. Scheenen, J. Fütterer, S. Bouwense, I. van Oort, F. Schröder, H. Huisman, J. BarentszEuropean Urology 2012;61:177–184&Immunocytology Is a Strong Predictor of Bladder Cancer Presence in Patients With Painless Hematuria: A Multicentre Study E.K. Cha, L.-A. Tirsar, C. Schwentner, P.J. Christos, C. Mian, J. Hennenlotter, T. Martini, A. Stenzl, A. Pycha, S.F. Shariat, B.J. Schmitz-DrägerEuropean Urology 2012;61:185–192

Page 4: Award pages

The PlatinumHall of Fame

Platinum Award Winners 20091. Fritz Schröder2. Urs Studer

Platinum Award Winners 20101. Christopher Chapple2. Oliver Hakenberg3. Rodolfo Montironi

Platinum Award Winners 20111. Guido Dalbagni2. Monique J. Roobol

Platinum Award Winners 20121. Anders Bjartell2. Markus Graefen3. Mani Menon4. Christian Stief5. Tullio Sulser6. Alexandre Zlotta

Platinum Award Winners 20131. Per-Anders Abrahamsson2. Walter Artibani3. Jacqueline Roelofswaard4. Maurice Schlief5. Claude Schulman6. Pierre Teillac7. Manfred Wirth8. Hendrik van Poppel

2007 Reviewers of the MonthJanuary: Massimo Maffezzini (Italy)February: Hiten R. H. Patel (UK)March: Pierre Karakiewicz (Canada)April: Christian Gratzke (Germany)May: Fred Witjes (The Netherlands)June: Ziya Kirkali (Turkey)July: Bertrand Guillonneau (USA)August: Chris Chapple (UK)September: Axel Heidenreich (Germany)October: Jean-Jacques Patard (France)November: Oliver Reich (Germany)

Reviewer of the Year 2007Vincenzo Ficarra (Italy)

2008 Reviewers of the MonthJanuary: Shahrokh Shariat (USA) February: Alberto Briganti (Italy)March: Alexander Bachmann (Switzerland)April: Scott Eggener (USA)May: Roger Dmochowski (USA)June: Felix K.-H. Chun (Germany)July: Giacomo Novara (Italy)August: Michael Blute (USA)September: Patrick Bastian (Germany)October: Rafael Badalyan (Armenia)November: Henk van der Poel (The Netherlands)

Reviewer of the Year 2008Pierre Karakiewicz (Canada)

2009 Reviewers of the MonthJanuary: Matthew Gettman (USA)February: Oliver Hakenberg (Germany)March: Riccardo Autorino (Italy)April: Urs Studer (Switzerland)May: Fritz Schröder (The Netherlands)June: Petrisor Geavlete (Romania)July: Clare Fowler (UK)August: Francisco Cruz (Portugal)September: John Denstedt (Canada)October: Jacques Irani (France)November: Apostolos Apostolidis (Greece)

Reviewer of the Year 2009Henk van der Poel (The Netherlands)

2010 Reviewers of the MonthJanuary: Ricarda Bauer (Germany)February: Declan Murphy (Australia)March: Harry Herr (USA)April: Marko Babjuk (Czech Republic)May: Umberto Capitanio (Italy)June: Stephen Freedland (USA)July: Richard Sylvester (Belgium)August: Rufus Cartwright (UK)September: Jens Rassweiler (Germany)October: Mike Kattan (USA)November: George Thalmann (Switzerland)

Reviewers of the Year 2010Michael Kattan (USA)Matthew Gettman (USA) Giacomo Novara (Italy)

Page 5: Award pages

The PlatinumHall of Fame

2011 Reviewers of the MonthJanuary: Ofer Yossepowitch (Israel)February: Theo de Reijke (The Netherlands)March: Evangelos Liatsikos (Greece)April: Christopher Eden (UK)May: Ofer Gofrit (Israel)June: James Catto (UK)July: R. Houston Thompson (USA)August: Karim Bensalah (France)September: Gianluca Giannarini (Italy)October: Mesut Remzi (Austria)November: Peter Albertsen (USA)

Reviewer of the Year 2011Alexander Bachmann (Switzerland)

2012 Reviewers of the MonthJanuary: Francesco Greco (Germany)February: Stephen Boorjian (USA)March: Jean-Nicolas Cornu (France)April: Mark Emberton (UK)May: Firas Abdollah (Italy)

June: Stephan Madersbacher (Austria)July: Michael Rink (Germany)August: Rik Bryan (UK)September: Sabine Brookman-May (Germany)October: Nicolas Mottet (France)November: Hendrik Isbarn (Germany)

Reviewers of the Year 2012Peter Albertsen (USA)Jean-Nicolas Cornu (France)Gianluca Giannarini (Switzerland)

2013 Reviewers of the MonthJanuary: Massimo Lazzeri (Italy)February: Guillaume Ploussard (France)March: Derya Tilki (Germany)April: Giuseppe Simone (Italy)May: Evanguelos Xylinas (USA)June: Joseph Chin (Canada)July: Rodolfo Montironi (Italy)August: Matthew Galsky (USA)